According to Galmed Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 6,246,188. At the end of 2023 the company had 6,246,188 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 6.24 M | 271.95% |
2022 | 1.67 M | 0.42% |
2021 | 1.67 M | 17.94% |
2020 | 1.41 M | 0.69% |
2019 | 1.4 M | 0.81% |
2018 | 1.39 M | 58.04% |
2017 | 0.88 M | 9.13% |
2016 | 0.8 M | 9.45% |
2015 | 0.74 M | 0% |
2014 | 0.74 M | 118.97% |
2013 | 0.33 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Evoke Pharma
EVOK | 3,343,070 | -46.48% | ๐บ๐ธ USA |
Endo International
ENDPQ | 235,220,000 | 3,665.82% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | 47,819,936 | 665.59% | ๐บ๐ธ USA |
Catalent CTLT | 182,000,000 | 2,813.78% | ๐บ๐ธ USA |